Does NIVOLUMAB Cause Musculoskeletal stiffness? 151 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 151 reports of Musculoskeletal stiffness have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.2% of all adverse event reports for NIVOLUMAB.
151
Reports of Musculoskeletal stiffness with NIVOLUMAB
0.2%
of all NIVOLUMAB reports
5
Deaths
50
Hospitalizations
How Dangerous Is Musculoskeletal stiffness From NIVOLUMAB?
Of the 151 reports, 5 (3.3%) resulted in death, 50 (33.1%) required hospitalization, and 4 (2.6%) were considered life-threatening.
Is Musculoskeletal stiffness Listed in the Official Label?
Yes, Musculoskeletal stiffness is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Musculoskeletal stiffness?
ADALIMUMAB (10,762)
METHOTREXATE (9,903)
ETANERCEPT (9,744)
TOFACITINIB (7,354)
TOCILIZUMAB (6,346)
RITUXIMAB (6,058)
LEFLUNOMIDE (6,031)
ABATACEPT (5,926)
SECUKINUMAB (5,655)
HYDROXYCHLOROQUINE (5,271)
Which NIVOLUMAB Alternatives Have Lower Musculoskeletal stiffness Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE